HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, announced the appointment of an interim chief financial officer; the company named Maria Leal, who is currently serving as both controller and company vice president, to the position. A CPA and MBA, Leal has built a strong reputation for strong financial management over the past two decades. She has served in a variety of financial accounting roles and landed at HempFusion in 2019. Management noted that Leal has been instrumental in all financial reporting aspects for the company since joining the company. Leal replaces Bruce Valentine, who served as chief financial officers before Leal, is resigning because of the unexpected death of his mother and the resulting duties that have arisen. “On behalf of the company and the employees of HempFusion, we send our deepest condolences to Bruce and his family for their loss,” said HempFusion CEO Jason Mitchell, ND, in the press release. “I would like to thank Bruce for his contributions to the company. The Board has begun a process to appoint a successor to Mr. Valentine and a further announcement will be made in due course. In the meantime, the board has full confidence that Ms. Leal will succeed in shepherding HempFusion’s finance and accounting functions. She has been an integral part of the development and implementation of the financial planning and accounting functions over the past several years.”
To view the full press release, visit https://ibn.fm/NJvBm
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
